395 related articles for article (PubMed ID: 20449641)
1. Epithelial-to-mesenchymal transitions and circulating tumor cells.
Bonnomet A; Brysse A; Tachsidis A; Waltham M; Thompson EW; Polette M; Gilles C
J Mammary Gland Biol Neoplasia; 2010 Jun; 15(2):261-73. PubMed ID: 20449641
[TBL] [Abstract][Full Text] [Related]
2. Epithelial-mesenchymal transition in cancer: parallels between normal development and tumor progression.
Micalizzi DS; Farabaugh SM; Ford HL
J Mammary Gland Biol Neoplasia; 2010 Jun; 15(2):117-34. PubMed ID: 20490631
[TBL] [Abstract][Full Text] [Related]
3. Cell polarity in motion: redefining mammary tissue organization through EMT and cell polarity transitions.
Godde NJ; Galea RC; Elsum IA; Humbert PO
J Mammary Gland Biol Neoplasia; 2010 Jun; 15(2):149-68. PubMed ID: 20461450
[TBL] [Abstract][Full Text] [Related]
4. The pathophysiology of epithelial-mesenchymal transition induced by transforming growth factor-beta in normal and malignant mammary epithelial cells.
Taylor MA; Parvani JG; Schiemann WP
J Mammary Gland Biol Neoplasia; 2010 Jun; 15(2):169-90. PubMed ID: 20467795
[TBL] [Abstract][Full Text] [Related]
5. Mammary gland studies as important contributors to the cause of epithelial mesenchymal plasticity in malignancy.
Ford HL; Thompson EW
J Mammary Gland Biol Neoplasia; 2010 Jun; 15(2):113-5. PubMed ID: 20544376
[No Abstract] [Full Text] [Related]
6. ErbB/EGF signaling and EMT in mammary development and breast cancer.
Hardy KM; Booth BW; Hendrix MJ; Salomon DS; Strizzi L
J Mammary Gland Biol Neoplasia; 2010 Jun; 15(2):191-9. PubMed ID: 20369376
[TBL] [Abstract][Full Text] [Related]
7. Matrix metalloproteinase-induced epithelial-mesenchymal transition in breast cancer.
Radisky ES; Radisky DC
J Mammary Gland Biol Neoplasia; 2010 Jun; 15(2):201-12. PubMed ID: 20440544
[TBL] [Abstract][Full Text] [Related]
8. Epithelial-mesenchymal transition (EMT) in tumor-initiating cells and its clinical implications in breast cancer.
Creighton CJ; Chang JC; Rosen JM
J Mammary Gland Biol Neoplasia; 2010 Jun; 15(2):253-60. PubMed ID: 20354771
[TBL] [Abstract][Full Text] [Related]
9. Epithelial mesenchymal transition traits in human breast cancer cell lines parallel the CD44(hi/)CD24 (lo/-) stem cell phenotype in human breast cancer.
Blick T; Hugo H; Widodo E; Waltham M; Pinto C; Mani SA; Weinberg RA; Neve RM; Lenburg ME; Thompson EW
J Mammary Gland Biol Neoplasia; 2010 Jun; 15(2):235-52. PubMed ID: 20521089
[TBL] [Abstract][Full Text] [Related]
10. microRNAs and EMT in mammary cells and breast cancer.
Wright JA; Richer JK; Goodall GJ
J Mammary Gland Biol Neoplasia; 2010 Jun; 15(2):213-23. PubMed ID: 20499142
[TBL] [Abstract][Full Text] [Related]
11. Snail family regulation and epithelial mesenchymal transitions in breast cancer progression.
de Herreros AG; Peiró S; Nassour M; Savagner P
J Mammary Gland Biol Neoplasia; 2010 Jun; 15(2):135-47. PubMed ID: 20455012
[TBL] [Abstract][Full Text] [Related]
12. A dynamic in vivo model of epithelial-to-mesenchymal transitions in circulating tumor cells and metastases of breast cancer.
Bonnomet A; Syne L; Brysse A; Feyereisen E; Thompson EW; Noël A; Foidart JM; Birembaut P; Polette M; Gilles C
Oncogene; 2012 Aug; 31(33):3741-53. PubMed ID: 22120722
[TBL] [Abstract][Full Text] [Related]
13. Analysis of the hormone receptor status of circulating tumor cell subpopulations based on epithelial-mesenchymal transition: a proof-of-principle study on the heterogeneity of circulating tumor cells.
Guan X; Ma F; Liu S; Wu S; Xiao R; Yuan L; Sun X; Yi Z; Yang H; Xu B
Oncotarget; 2016 Oct; 7(40):65993-66002. PubMed ID: 27602758
[TBL] [Abstract][Full Text] [Related]
14. The prognostic and therapeutic implications of circulating tumor cell phenotype detection based on epithelial-mesenchymal transition markers in the first-line chemotherapy of HER2-negative metastatic breast cancer.
Guan X; Ma F; Li C; Wu S; Hu S; Huang J; Sun X; Wang J; Luo Y; Cai R; Fan Y; Li Q; Chen S; Zhang P; Li Q; Xu B
Cancer Commun (Lond); 2019 Jan; 39(1):1. PubMed ID: 30606259
[TBL] [Abstract][Full Text] [Related]
15. The pathology of EMT in mouse mammary tumorigenesis.
Cardiff RD
J Mammary Gland Biol Neoplasia; 2010 Jun; 15(2):225-33. PubMed ID: 20521088
[TBL] [Abstract][Full Text] [Related]
16. Stem cell and epithelial-mesenchymal transition markers are frequently overexpressed in circulating tumor cells of metastatic breast cancer patients.
Aktas B; Tewes M; Fehm T; Hauch S; Kimmig R; Kasimir-Bauer S
Breast Cancer Res; 2009; 11(4):R46. PubMed ID: 19589136
[TBL] [Abstract][Full Text] [Related]
17. Epithelial-to-mesenchymal transition leads to disease-stage differences in circulating tumor cell detection and metastasis in pre-clinical models of prostate cancer.
Lowes LE; Goodale D; Xia Y; Postenka C; Piaseczny MM; Paczkowski F; Allan AL
Oncotarget; 2016 Nov; 7(46):76125-76139. PubMed ID: 27764810
[TBL] [Abstract][Full Text] [Related]
18. EpCAM-independent isolation of circulating tumor cells with epithelial-to-mesenchymal transition and cancer stem cell phenotypes using ApoStream® in patients with breast cancer treated with primary systemic therapy.
Le Du F; Fujii T; Kida K; Davis DW; Park M; Liu DD; Wu W; Chavez-MacGregor M; Barcenas CH; Valero V; Tripathy D; Reuben JM; Ueno NT
PLoS One; 2020; 15(3):e0229903. PubMed ID: 32214335
[TBL] [Abstract][Full Text] [Related]
19. Epithelial-mesenchymal transition in tumor metastasis.
Yeung KT; Yang J
Mol Oncol; 2017 Jan; 11(1):28-39. PubMed ID: 28085222
[TBL] [Abstract][Full Text] [Related]
20. Hybrid epithelial/mesenchymal phenotype(s): The 'fittest' for metastasis?
Jolly MK; Mani SA; Levine H
Biochim Biophys Acta Rev Cancer; 2018 Dec; 1870(2):151-157. PubMed ID: 29997040
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]